Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oculomotor and Vestibular Findings in Gaucher Disease Type 3 and Their Correlation with Neurological Findings.
Bremova-Ertl T, Schiffmann R, Patterson MC, Belmatoug N, Billette de Villemeur T, Bardins S, Frenzel C, Malinová V, Naumann S, Arndt J, Mengel E, Reinke J, Strobl R, Strupp M. Bremova-Ertl T, et al. Among authors: billette de villemeur t. Front Neurol. 2018 Jan 15;8:711. doi: 10.3389/fneur.2017.00711. eCollection 2017. Front Neurol. 2018. PMID: 29379464 Free PMC article.
[Gaucher's disease ].
Belmatoug N, Caubel I, Stirnemann J, Billette de Villemeur T. Belmatoug N, et al. Among authors: billette de villemeur t. J Soc Biol. 2002;196(2):141-9. J Soc Biol. 2002. PMID: 12360743 Review. French.
[Gaucher disease].
Kaminsky P, Belmatoug N, Billette de Villemeur T. Kaminsky P, et al. Among authors: billette de villemeur t. Presse Med. 1996 Jan 27;25(3):108-12. Presse Med. 1996. PMID: 8746084 Review. French.
Optimization of ultra-high pressure liquid chromatography - tandem mass spectrometry determination in plasma and red blood cells of four sphingolipids and their evaluation as biomarker candidates of Gaucher's disease.
Chipeaux C, de Person M, Burguet N, Billette de Villemeur T, Rose C, Belmatoug N, Héron S, Le Van Kim C, Franco M, Moussa F. Chipeaux C, et al. Among authors: billette de villemeur t, de person m. J Chromatogr A. 2017 Nov 24;1525:116-125. doi: 10.1016/j.chroma.2017.10.038. Epub 2017 Oct 14. J Chromatogr A. 2017. PMID: 29061473
[French results of enzyme replacement therapy in Gaucher's disease].
Schaison G, Caubel I, Belmatoug N, Billette de Villemeur T, Saudubray JM. Schaison G, et al. Among authors: billette de villemeur t. Bull Acad Natl Med. 2002;186(5):851-61; discussion 861-3. Bull Acad Natl Med. 2002. PMID: 12412377 French.
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, Levade T, Astudillo L, Serratrice J, Brassier A, Rose C, Billette de Villemeur T, Berger MG. Stirnemann J, et al. Among authors: billette de villemeur t. Int J Mol Sci. 2017 Feb 17;18(2):441. doi: 10.3390/ijms18020441. Int J Mol Sci. 2017. PMID: 28218669 Free PMC article. Review.
Semaphorin 7A: A novel marker of disease activity in Gaucher disease.
Franco M, Reihani N, Dupuis L, Collec E, Billette de Villemeur T, de Person M, Moussa F, Berger MG, Belmatoug N, Le Van Kim C. Franco M, et al. Among authors: billette de villemeur t, de person m. Am J Hematol. 2020 May;95(5):483-491. doi: 10.1002/ajh.25744. Epub 2020 Feb 7. Am J Hematol. 2020. PMID: 31990411 Free article.
143 results